These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1413533)

  • 1. [Immune response to HTLV-I infection].
    Sonoda S
    Uirusu; 1992 Jun; 42(1):29-39. PubMed ID: 1413533
    [No Abstract]   [Full Text] [Related]  

  • 2. Polymorphisms in HLA-C and KIR alleles are not associated with HAM/TSP risk in HTLV-1-infected subjects.
    Assone T; Malta FM; Bakkour S; Montalvo L; Paiva AM; Smid J; de Oliveira ACP; de Toledo Gonçalves F; do Carmo Luiz O; Fonseca LAM; Norris PJ; Casseb J
    Virus Res; 2018 Jan; 244():71-74. PubMed ID: 29129607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HTLV-1 and tropical spastic paraparesis. 2. The human T-cell lymphotropic virus type 1.
    Weber J
    Trans R Soc Trop Med Hyg; 1989; 83(6):729-31. PubMed ID: 2617642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human T-cell lymphotropic virus type I and neurological diseases.
    Nagai M; Osame M
    J Neurovirol; 2003 Apr; 9(2):228-35. PubMed ID: 12707853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis.
    Parker CE; Daenke S; Nightingale S; Bangham CR
    Virology; 1992 Jun; 188(2):628-36. PubMed ID: 1374983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HTLV-1 infections.
    Bangham CR
    J Clin Pathol; 2000 Aug; 53(8):581-6. PubMed ID: 11002759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection.
    Jeffery KJ; Siddiqui AA; Bunce M; Lloyd AL; Vine AM; Witkover AD; Izumo S; Usuku K; Welsh KI; Osame M; Bangham CR
    J Immunol; 2000 Dec; 165(12):7278-84. PubMed ID: 11120862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Seroprevalence of HTLV-I in relatives of patients with spastic paraparesis (HAM/TSP and PEP)].
    Cartier L; Vergara C; Ramírez E; Casivar T; Vásquez A
    Rev Med Chil; 1995 Jan; 123(1):7-11. PubMed ID: 7569448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopathogenesis and neurological manifestations associated to HTLV-1 infection.
    Souza A; Tanajura D; Toledo-Cornell C; Santos S; Carvalho EM
    Rev Soc Bras Med Trop; 2012 Oct; 45(5):545-52. PubMed ID: 23152334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetic diversity of HLA in HTLV-I infection].
    Sonoda S; Fujiyoshi T; Yashiki S; Li HC; Lou H; Lema C
    Uirusu; 2000 Jun; 50(1):37-45. PubMed ID: 10998977
    [No Abstract]   [Full Text] [Related]  

  • 11. Patterns of HTLV-I infection among family members of patients with adult T-cell leukemia/lymphoma and HTLV-I associated myelopathy/tropical spastic paraparesis.
    Wilks R; Hanchard B; Morgan O; Williams E; Cranston B; Smith ML; Rodgers-Johnson P; Manns A
    Int J Cancer; 1996 Jan; 65(2):272-3. PubMed ID: 8567128
    [No Abstract]   [Full Text] [Related]  

  • 12. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
    Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
    Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible HLA association with susceptibility to HTLV-1 tropical spastic paraparesis in Israel in Iranian Jews as compared to HTLV 1-associated myelopathy in Japan.
    Shohat B; Achiron A; Narinski R; Kochba I; Sidi Y; Sonada S; Osame M; Klein T
    Tissue Antigens; 1996 Aug; 48(2):136-8. PubMed ID: 8883303
    [No Abstract]   [Full Text] [Related]  

  • 14. HTLV-1: persistence and pathogenesis.
    Cook LB; Elemans M; Rowan AG; Asquith B
    Virology; 2013 Jan; 435(1):131-40. PubMed ID: 23217623
    [No Abstract]   [Full Text] [Related]  

  • 15. Lack of association between single-nucleotide polymorphisms of pro- and anti-inflammatory cytokines and HTLV-1-associated myelopathy / tropical spastic paraparesis development in patients from Rio de Janeiro, Brazil.
    Schor D; Porto LC; Roma EH; Quintana MSB; Fabricio-Silva GM; Bonecini-Almeida MG; Araújo AQ; Andrada-Serpa MJ
    BMC Infect Dis; 2018 Nov; 18(1):593. PubMed ID: 30466392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal trends in Human T-Lymphotropic virus 1 (HTLV-1) associated myelopathy/tropical spastic paraparesis (HAM/TSP) incidence in Martinique over 25 years (1986-2010).
    Olindo S; Jeannin S; Saint-Vil M; Signate A; Edimonana-Kaptue M; Joux J; Merle H; Richard P; Granjeaud S; Cabre P; Smadja D; Cesaire R; Lezin A
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006304. PubMed ID: 29554087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell maturation, but not type I interferon exposure, restricts infection by HTLV-1, and viral transmission to T-cells.
    Rizkallah G; Alais S; Futsch N; Tanaka Y; Journo C; Mahieux R; Dutartre H
    PLoS Pathog; 2017 Apr; 13(4):e1006353. PubMed ID: 28426803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HTLV-I-associated myelopathy (HAM)].
    Izumo S
    Uirusu; 2002 Dec; 52(2):239-44. PubMed ID: 12685314
    [No Abstract]   [Full Text] [Related]  

  • 19. HTLV-1: A real pathogen or a runaway guest of a diseased cell?
    Kanzaki LIB
    J Biosci; 2018 Sep; 43(4):785-795. PubMed ID: 30207322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease.
    Jacobson S; Shida H; McFarlin DE; Fauci AS; Koenig S
    Nature; 1990 Nov; 348(6298):245-8. PubMed ID: 2146511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.